Article snapshot taken from Wikipedia with creative commons attribution-sharealike license.
Give it a read and then ask your questions in the chat.
We can research this topic together.
This is an old revision of this page, as edited by MaxPont (talk | contribs) at 08:49, 31 May 2009 (add timeline (it might be forgotten otherwise). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Expand : Why the US approval process caused controversy
Charges of COI in DOJ handling of FDA's Fraud allegations against Searle.
Charges of COI in hirings of 6 FDA personnel (described in GAO 86 report to Metzenbaum)
Studies by Olney and others dismissed.
Expand and integrate the timeline in the article
Charges of COI when new FDA commissioner overturned unanimous decision of PBOI
Senator Metzenbaum's role in returning the controversy to the news.
Why the Ramazzinni studies contribute to the controversy
Allegations of COI in industry-funded critiques of Soffritti studies
...
NPOV : Remember that some parts of this article follow WP:MEDRS and must reflect the preponderance of medical opinion, while other parts of this article follow WP:CONTROVERSY and must explain the controversy.
Verify : Different types of sources are appropriate to different sections of this article.